H.I.G. Capital Acquires SkinCure Oncology

October 1, 2024

H.I.G. Capital, through an affiliate, completed the acquisition of SkinCure Oncology Intermediate LLC, a Burr Ridge, Illinois–headquartered provider of image-guided superficial radiation therapy (IG-SRT) for nonmelanoma skin cancer. SkinCure's executive team, led by CEO Kerwin Brandt, will remain in place and significant shareholders; Marathon Asset Management provided a senior-secured credit facility to finance the transaction. The investment aims to support expansion of the GentleCure platform across existing and new dermatology and Mohs practice partners nationwide.

Buyers
H.I.G. Capital
Targets
SkinCure Oncology Intermediate LLC
Location
Illinois, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.